MediXall Group Past Earnings Performance
Past criteria checks 0/6
MediXall Group's earnings have been declining at an average annual rate of -10.8%, while the Healthcare Services industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 295.3% per year.
Key information
-10.8%
Earnings growth rate
1.1%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 295.3% |
| Return on equity | n/a |
| Net Margin | -12,053.4% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How MediXall Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -7 | 3 | 0 |
| 30 Sep 22 | 0 | -7 | 3 | 0 |
| 30 Jun 22 | 0 | -7 | 3 | 0 |
| 31 Mar 22 | 0 | -8 | 3 | 0 |
| 31 Dec 21 | 0 | -6 | 3 | 0 |
| 30 Sep 21 | 0 | -7 | 4 | 0 |
| 30 Jun 21 | 0 | -6 | 3 | 0 |
| 31 Mar 21 | 0 | -6 | 3 | 0 |
| 31 Dec 20 | 0 | -6 | 3 | 0 |
| 30 Sep 20 | 0 | -5 | 3 | 0 |
| 30 Jun 20 | 0 | -5 | 3 | 0 |
| 31 Mar 20 | 0 | -5 | 2 | 0 |
| 31 Dec 19 | 0 | -3 | 2 | 0 |
| 30 Sep 19 | 0 | -3 | 2 | 0 |
| 30 Jun 19 | 0 | -3 | 2 | 0 |
| 31 Mar 19 | 0 | -3 | 1 | 0 |
| 31 Dec 18 | 0 | -3 | 1 | 0 |
| 30 Sep 18 | 0 | -3 | 1 | 0 |
| 30 Jun 18 | 0 | -2 | 1 | 0 |
| 31 Mar 18 | 0 | -2 | 1 | 0 |
| 31 Dec 17 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -1 | 1 | 0 |
| 30 Jun 17 | 0 | -1 | 1 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 0 | 0 |
Quality Earnings: MDXL is currently unprofitable.
Growing Profit Margin: MDXL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MDXL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MDXL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDXL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: MDXL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.